Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition.

Independent of heparin exposure, patients in the primary cohort (INR ≥ 1.2) who had infection documented by positive blood culture exhibited a strong trend toward reduced mortality when they were given tifacogin rather than placebo (mortality rate 27.7% versus 35.4%; P = 0.054).

also in 5,725 other papers